Bio-Rad Laboratories (BIO) Competitors $283.92 -2.57 (-0.90%) As of 09/19/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Its Competitors Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings. Do insiders and institutionals have more ownership in BIO or MTD? 65.2% of Bio-Rad Laboratories shares are held by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are held by institutional investors. 17.1% of Bio-Rad Laboratories shares are held by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend BIO or MTD? Bio-Rad Laboratories currently has a consensus price target of $333.50, suggesting a potential upside of 17.46%. Mettler-Toledo International has a consensus price target of $1,311.11, suggesting a potential upside of 3.66%. Given Bio-Rad Laboratories' stronger consensus rating and higher probable upside, equities analysts plainly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Mettler-Toledo International 0 Sell rating(s) 5 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to BIO or MTD? In the previous week, Mettler-Toledo International had 7 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 14 mentions for Mettler-Toledo International and 7 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.64 beat Bio-Rad Laboratories' score of 1.21 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 14 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has more risk & volatility, BIO or MTD? Bio-Rad Laboratories has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.37, meaning that its share price is 37% more volatile than the S&P 500. Which has higher valuation & earnings, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.57B2.99-$1.84B$11.7324.20Mettler-Toledo International$3.87B6.73$863.14M$39.4932.03 Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 21.46% compared to Bio-Rad Laboratories' net margin of 12.50%. Bio-Rad Laboratories' return on equity of 4.01% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories12.50% 4.01% 2.82% Mettler-Toledo International 21.46%-476.07%26.05% SummaryMettler-Toledo International beats Bio-Rad Laboratories on 12 of the 16 factors compared between the two stocks. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$7.69B$10.70B$5.79B$21.65BDividend YieldN/A1.89%5.61%3.52%P/E Ratio24.2013.8660.4927.35Price / Sales2.9931.92538.7560.84Price / Cash27.3424.5137.6624.98Price / Book1.213.4215.754.59Net Income-$1.84B$210.63M$3.30B$1.00B7 Day Performance1.28%-0.02%5.36%0.81%1 Month Performance-1.39%1.47%8.10%5.42%1 Year Performance-13.96%-9.87%81.36%14.47% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.6254 of 5 stars$283.92-0.9%$333.50+17.5%-17.6%$7.69B$2.57B24.207,700Positive NewsMTDMettler-Toledo International4.1516 of 5 stars$1,314.38+0.7%$1,311.11-0.2%-12.3%$26.90B$3.87B33.2817,300Positive NewsWATWaters4.8035 of 5 stars$309.58+1.1%$378.73+22.3%-11.0%$18.23B$2.96B27.927,600Trending NewsILMNIllumina4.7398 of 5 stars$98.18-0.8%$123.06+25.3%-23.5%$15.21B$4.37B12.439,030Positive NewsTECHBio-Techne4.986 of 5 stars$54.11-0.6%$70.42+30.1%-33.9%$8.53B$1.22B117.633,100Positive NewsCRLCharles River Laboratories International4.6262 of 5 stars$161.97-1.2%$175.69+8.5%-25.8%$8.07B$4.05B-121.7820,100Positive NewsAnalyst RevisionBRKRBruker4.9655 of 5 stars$30.80-0.1%$51.30+66.6%-51.4%$4.68B$3.37B59.2311,396Short Interest ↑Analyst RevisionPACBPacific Biosciences of California1.9032 of 5 stars$1.25-1.6%$1.90+52.0%-37.7%$381.47M$154.01M-0.55730HBIOHarvard Bioscience4.0953 of 5 stars$0.45-4.9%$3.00+559.9%-83.1%$21.30M$94.14M-0.35490Positive NewsShort Interest ↑Gap DownTMOThermo Fisher Scientific4.9677 of 5 stars$487.11-1.1%$589.38+21.0%-22.6%$186.01B$42.88B28.17125,000Positive NewsAAgilent Technologies4.4823 of 5 stars$128.13-0.5%$139.25+8.7%-11.1%$36.50B$6.51B30.0817,900Dividend Announcement Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BIO) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
